News and Trends 12 May 2023
Achilles Therapeutics’ new platform identifies most potent T-cell antigens
Achilles Therapeutics plc says its newly-developed AI application, trained with proprietary real-world data, outperformed current AI and non-AI methods for neoantigen immunogenicity prediction in a recent analysis, enabling the identification…
